{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:56:50Z","timestamp":1695509810008},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":684,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jhep.2011.01.012","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T09:14:54Z","timestamp":1296551694000},"page":"510-511","source":"Crossref","is-referenced-by-count":8,"title":["Role of mycophenolate mofetil in the treatment of autoimmune hepatitis"],"prefix":"10.1016","volume":"55","author":[{"given":"Christoph","family":"Schramm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2011.01.012_b0005","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.01.012_b0010","unstructured":"Lohse AW, Mieli-Vergani G. Autoimmune Hepatitis. J Hepatol 2010 [Epub ahead of print]."},{"key":"10.1016\/j.jhep.2011.01.012_b0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-13708","article-title":"Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience","volume":"39","author":"Kanzler","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2011.01.012_b0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.01.012_b0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1572-0241.2005.41598.x","article-title":"Increased rates of early adverse reaction to azathioprine in patients with Crohn\u2019s disease compared to autoimmune hepatitis: a tertiary referral center experience","volume":"100","author":"Bajaj","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.01.012_b0030","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.01.012_b0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.01.012_b0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jhep.2011.01.012_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00063030-199912050-00005","article-title":"Mycophenolate mofetil: a review of its use in the management of solid organ transplantation","volume":"12","author":"Bardsley-Elliot","year":"1999","journal-title":"BioDrugs"},{"key":"10.1016\/j.jhep.2011.01.012_b0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/TP.0b013e318199c1c7","article-title":"Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation","volume":"87","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2011.01.012_b0055","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1600-6143.2009.02705.x","article-title":"Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil","volume":"9","author":"Germani","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2011.01.012_b0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.autrev.2006.11.001","article-title":"Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?","volume":"6","author":"Iaccarino","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2011.01.012_b0065","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2011.01.012_b0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2011.01.012_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.01.012_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365520903555861","article-title":"Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response","volume":"45","author":"Werner","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.01.012_b0085","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/MCG.0b013e318154af74","article-title":"Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis","volume":"42","author":"Luth","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2011.01.012_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14656566.7.2.145","article-title":"Cost-effectiveness of pharmacotherapy for autoimmune hepatitis","volume":"7","author":"Heneghan","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhep.2011.01.012_b0095","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","article-title":"Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding","volume":"16","author":"Gisbert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2011.01.012_b0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:56:09Z","timestamp":1543985769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827811000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0168827811000808"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2011.01.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}